Updates

The electronic informed consent worksheet, required for all expedited and full board protocols, as well as exempt, NHSR, and flex submissions with PHI has been updated and consolidated. There is now one worksheet option, regardless of protocol type. Please visit the WVU OHRP Forms page to download the most up-to-date version of the document. For questions or concerns, please email IRB@mail.wvu.edu.

The WVU Office of Human Research Protections is offering Office Hours via Zoom to provide support to the research community. Investigators, research staff, and/or students are encouraged to drop into these sessions at their convenience with questions about ongoing research, developing research projects, the WVU+kc system, general IRB considerations, etc. A variety of staff from OHRP will be available to answer questions and provide support. Contact Kasandra Lambert for questions. Stay up to date by visiting the OHRP calendar periodically and keep an eye out for email reminders from the WVU+kc users listserv.

WVU OHRP has released new/revised informed consent templates.

Procurement, Contracting, and Payment Services PCPS announced on May 31, 2022, that West Virginia University has selected Prepaid Technologies as its new provider for prepaid card services. Please visit procurement.wvu.edu for more information.

Changes to IRB Fees, Billing Practices, and Collections Effective April 1, 2022

In an effort to further reduce investigator burden, more closely harmonize with DHHS New Common Rule changes to Expedited reviews, and prepare for a new KC system (possibly later this year), WVU is modifying how it currently reviews and approves Expedited studies. Because of these changes, you may be required to take action.

To remain compliant with FDA and DHHS Common Rule regulations and to protect the integrity of WVU’s AAHRPP Accreditation status and Federalwide Assurance (FWA), WVU OHRP will be making changes regarding protocol expiration policies.

Dear Research Community:

Dear Research Community:

Please review this letter from Dr. Fred King regarding research studies studies that involve DOD funding and/or include DOD personnel as a targeted population.